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“Extended” Distal Pancreatectomy with Segmental 
Resection of Both Splenic Vessels; Extended Warshaw’s 
Procedure
Purpose: We would like to assess the safety and feasibility of extended spleen-preserving 
distal pancreatectomy with segmental resection of both splenic vessels (SPDP-SRSV) in patients 
with large, benign and borderline malignant pancreas body tumors.
Methods: We encountered seven extended SPDP-SRSV cases from January 2006 to March 
2010. Among them, three were excluded due to combined pylorus-reserving pancreaticodu-
odenectomy (PPPD). For the extended surgical technique, the pancreas was divided above 
the confluence of the superior mesenteric vein-splenic vein-portal vein (SMV-SV-PV), and vascular 
control was achieved at the origin of the splenic artery and the junction of the splenic vein 
with the SMV. The segments of both splenic vessels were then extracted along with the specimen.
Results: All the patients were female with a median age of 57 years (range: 24∼70 years). 
The median tumor size was 5.5 cm (range: 5∼11 cm), the median operation time was 362 
minutes (range: 337∼441 min), the median estimated blood loss was 150 ml (range: 50∼300 
ml) and the median hospital stay was 9 days (range: 7∼20 days). One patient underwent 
robot-assisted extended Warshaw procedures. No mortality was noted, but one partial intestinal 
obstruction occurred and this was resolved with conservative management. On the recent 
follow-up, the CT scans showed no evidence of tumor recurrence or spleen infarction, but newly 
developed perigastric varix was noted, but it was without variceal bleeding.
Conclusion: SPDP-SRSV with division of the pancreatic neck portion above the confluence 
of the SMV-SV-PV in patients with large, benign and borderline malignant pancreatic body tumors 
appears to be an ideal approach because of the expected long-term survival and preserving 
the role of the spleen.
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Introduction
  During recent years, laparoscopic SPDP has been widely 
applied for benign and borderline malignant tumors 
requiring distal pancreatectomy. The rationale for spleen- 
preserving procedures comprises prevention of posto-
perative infection-related complications including overwhel-
ming postsplenectomy infection syndrome (OPSI)1-3 as well 
as a possible advantage regarding reduced carcinoge-
nesis.2,4 In general, there are two surgical techniques for 
preservation of the spleen in distal pancreatectomy. First, 
the spleen can be safely preserved by simply conserving 
both splenic artery and vein during distal pancreatectomy; 
however, this technique is time- and labor-consuming, and 
may be difficult in cases of large left-sided pancreatic 
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Fig. 1. Preoperative image in case number 2. About large 6
cm-sized pancreatic cyst was noted in the body of the pancreas
of a 24-year-old patient. Tumor was closely abutted with both
splenic artery and vein.
tumors and pancreatic pathologies associated with chronic 
pancreatitis. The other technique, the so-called “Warshaw 
procedure”, combines distal pancreatectomy with segmen-
tal resection of both splenic vessels, leaving the spleen 
perfused with the intact left gastroepiploric vessels and 
short gastric vessels,5,6 This technique is quick and relatively 
easy, omitting individual vascular control of small tributary 
vessels between the pancreas and both splenic vessels. 
However, spleen-related postoperative complications, such 
as splenic infarction and abscess, need to be considered 
and the potential risk of postoperative gastric varix and 
bleeding is another controversial issue.7,8
  Crippa et al.9 called distal pancreatectomy an “extended” 
distal pancreatectomy when the pancreas was divided at 
the level of SMV-SV-PV confluence. Thus, when the 
pancreas is divided at the level of the SMV-SV-PV 
confluence and the splenic artery and vein are securely 
controlled at the origin of the vessels, we specifically call 
this, an “extended” Warshaw procedure instead. We 
recently encountered four cases of extended Warshaw 
procedure in large benign and borderline malignant tumor 
of the pancreas, In this study, we retrospectively evaluated 
the surgical outcome of this technique and discussed the 
technical feasibility of this procedure. 
Methods
  This was a retrospective study design. Between January 
2006 and March 2010, a total of 7 patients underwent 
“extended” Warshaw procedure due to large benign and 
borderline malignant tumor of the pancreas (Fig. 1). 
Among them, three patients underwent combined PPPD for 
complete removal of an intraductal papillary mucin- 
producing tumor involving the entire pancreas and were 
excluded from the current study. General characteristics of 
patients were reviewed and perioperative surgical out-
comes, including spleen perfusion and perigastric fundal 
varix, were summarized (Table 1). 
  Operative techniques: The techniques for minimally 
invasive surgery and conventional open surgery are similar. 
In brief, the gastrocolic ligament was divided to expose the 
entire pancreas. The lower border of the pancreatic neck 
portion was carefully dissected to separate it from the portal 
vein and the pancreatic neck area. After making a complete 
window between the pancreas and the portal vein (Fig. 
2A), the pancreas was divided by endo-GIA. The 
splenocolic and gastrosplenic ligaments were not divided 
and the spleen was not mobilized. The upper part of the 
remnant pancreas was carefully dissected to isolate the 
origin of the splenic artery. It seems to be easier to 
approach the origin of the splenic vessels after division of 
the pancreatic neck portion. Vascular control can be 
obtained at the origin of the splenic artery and the junction 
of the splenic vein joined with the superior mesenteric vein 
(Fig. 2B, C). The coronary vein may or may not be divided 
during the operation. The distal part of the splenic vessel 
was simultaneously divided with vascular endo-GIA near 
the splenic hilar area, and the left gastroepiploric vessels 
were conserved (Fig. 2D). The pancreas was easily deta-
ched from the retroperitoneal space. Sometimes, the spleen 
perfusion was rechecked by intraoperative ultrasound in 
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Fig. 2. Operative view of case number 2 (Robot-assisted extended Warshaw procedure). Complete window between SMV-SV-PV 
confluence and pancreatic neck portion was made (A). The origin of splenic artery and splenic vein at the junction with SMV
were securely ligated and divided (B, C). Spleen was well preserved with good splenic perfusion and division site (black arrow) 
of distal part of splenic vessels was noted (D).
Doppler mode. Two closed suction drains were placed 
around the surgical field. 
Results
1. Preoperative characteristics and perioperative 
surgical outcome
  One patient underwent robot-assisted extended Warshaw 
procedures (Fig. 2, 3A, B). All patients were female with 
a median age of 57 years (range, 24∼76 years), a median 
tumor size of 5.2 cm (range, 2.5∼11 cm), a median 
operation time of 349.2 minutes (range, 200∼441 min), a 
median estimated blood loss of 125 ml (range, 50∼300 ml), 
and a median hospital stay of 8.5 days (range, 7∼20 days) 
postoperatively. Chronic inflammatory change of the 
pancreas was noted in all patients. One patient showed 
about 2-cm sized low attenuated spleen lesion at CT scan 
taken on postoperative 7th day, but had no symptom related 
to this finding. One patient experienced postoperative 
partial intestinal obstruction, but it was successfully treated 
by conservative management. No mortality was noted 
(Table 1).  
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Fig. 3. Surgical specimen and follow up CT scan in case number 2. Final pathologic report was mucinous cyst adenoma (A and
B) and follow-up CT scan showed naturally developed collateral venous circulation around gastric fundus (C and D). 
Table 1. Perioperative clinicopathologic characteristics
Case Age/ Op. time Bleeding LOH∥ Cx¶ Focal spleen FU dura-Dx Size                          GVx**number Sex (cm) (min) (ml) (days) infarction tion‡‡(months)
  1 57/F  SCT† 11.00 362.00 150.00 20.00 Partial - 18. ＋
                                                                  Intestinal
                                                                  Obstruction
  2* 24/F  MCT‡  5.50 441.00  50.00  7.00 - -  6 ＋
  3 70/F  IPMT§  5.00 337.00 300.00  9.00 - +  2   NA††
  4 76/F IPMT  2.00 200.00 100.00  8.00 - - NA NA
*Robot-assisted, the others were open surgery; †SCT=serous cystic tumor; ‡MCT=mucinous cystic tumor; §IPMT=intraductal 
papillary mucin-producing tumor; ∥LOH=length of hospital stay following operation; ¶Cx=complication; **GVx=perigastric varix 
noted on FU CT scan; ††NA=not available, but will be followed up 6 month later; ‡‡FU=follow-up
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2. Short-term follow-up results
  During the recent follow-up period (6∼34 months), all 
patients appeared in good health condition. Follow-up CT 
scan (except last patient) showed no evidence of tumor 
recurrence and spleen infarction, but newly developed 
perigastric varix was noted (Fig. 3C, D). However, no one 
experienced clinically relevant variceal bleeding (Table 1).
Discussion
  Advanced surgical techniques can provide patients with 
safe and adequate management of their disease entities. 
Surgeons should consider patients’ quality of life when 
treating patients with benign or borderline malignant tumor 
of the pancreas because long-term survival is highly 
expected, unlike for those with pancreatic cancers. 
Recently, benign and borderline pancreatic tumors without 
specific clinical symptoms seem to be discovered more 
frequently. Function-preserving minimally invasive surgery 
seems to be an ideal approach for these tumors. 
  In the past, the spleen was removed when performing 
distal pancreatectomy due to its anatomic intimacy with the 
tail of the pancreas and the technical difficulty associated 
with conserving both splenic vessels. However, the clinical 
significance of the spleen has been emphasized1 and many 
surgeons have recently been trying to preserve the spleen 
whenever possible in cases of benign or borderline 
malignant pancreatic pathologies requiring distal pancrea-
tectomy. 
  For the purpose of increasing the technical feasibility and 
reducing the operation time, another spleen-preserving 
technique has been introduced that involves segmental 
resection of both splenic artery and vein. In this technique, 
surgeons do not need to individually control small tributary 
vessels between pancreas and splenic vessels to conserve 
the spleen. En-block resection of the distal pancreas with 
the segment of both splenic vessels reduces surgical time 
and technical efforts and spares the spleen. The spleen can 
survive by perfusion of short gastric vessels and left 
gastroepiploric vessels splenorenal and splenocolic vessels. 
Spleen-related postoperative morbidity and perigastric varix 
are complications to consider after Warshaw procedure. 
One patient was noted to have a small area of spleen 
infraction on postoperative CT scan, but it was not clinically 
significant. In addition, follow-up study showed newly 
developed perigastric varix in two patients, but there were 
no evidence of gastrointestinal bleeding from the fundal 
varix. In fact, Warshaw also noted that perigastric venous 
collateral development following the Warshaw procedure 
was a natural compensating process and did not have 
significant clinical adverse impact, indicating the safety and 
efficacy of the original technique.6 
  Most cases of distal pancreatectomy with segmental 
resection of splenic vessels may require division some-
where in the body or tail of the pancreas. In this report, 
we report four consecutive patients who underwent 
“extended” Warshaw procedure dividing pancreatic neck 
portion above SMV-SV-PV confluence with vascular control 
at the origin of the splenic artery and splenic vein. We 
observed no severe complication or mortality. One patient 
experienced postoperative partial obstruction that was 
managed conservatively. In addition, a young female 
patient successfully underwent minimally invasive approach 
(robot-assisted). Therefore, we suggest that the “extended” 
Warshaw procedure is also a feasible and safe surgical 
approach. Large benign or borderline malignant pancreatic 
body pathologies associated with chronic pancreatitis are 
thought to be good indications for this technique. 
  In summary, extended SPDP with segmental resection of 
both splenic vessels is feasible and can be safely applied 
to large benign and borderline malignant pancreatic body 
pathology considering the expected long-term survival and 
the role of the spleen. 
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